Literature DB >> 19255872

Tolerance to fast: rational and practical evaluation in children with hypoketonaemia.

J H Walter1.   

Abstract

Prolonged fasting in children with disorder of fat oxidation or ketone body synthesis can lead not only to hypoglycaemia but also to the accumulation of toxic metabolites. The length of time such patients can be safely fasted is important information for caregivers. Most children with MCAD deficiency when well can tolerate 'normal' periods without food, but in more severe disorders such as LCHAD deficiency even these may be associated with acute or chronic damage. Guidelines have been published for safe fasting periods in MCAD but not in other conditions. In the absence of such recommendations, a rational approach must be based on an understanding of the normal physiology of fasting in children of different ages and the pathophysiology associated with the child's particular disorder. Intercurrent infections pose a particular risk and may significantly reduce fasting tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255872     DOI: 10.1007/s10545-009-1087-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  Very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: monitoring of treatment by carnitine/acylcarnitine analysis in blood spots.

Authors:  U Spiekerkötter; B Schwahn; H Korall; F K Trefz; B S Andresen; U Wendel
Journal:  Acta Paediatr       Date:  2000-04       Impact factor: 2.299

2.  Glycemic response to 24-hour fast in normal children: III. Influence of age.

Authors:  J L Chaussain; P Georges; L Calzada; J C Job
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

3.  Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency.

Authors:  Melanie B Gillingham; Richard G Weleber; Martha Neuringer; William E Connor; Monte Mills; Sandy van Calcar; James Ver Hoeve; Jon Wolff; Cary O Harding
Journal:  Mol Genet Metab       Date:  2005-07-22       Impact factor: 4.797

4.  Safe and unsafe duration of fasting for children with MCAD deficiency.

Authors:  Terry G J Derks; Francjan J van Spronsen; Jan Peter Rake; Christian S van der Hilst; Mark M Span; G Peter A Smit
Journal:  Eur J Pediatr       Date:  2006-06-21       Impact factor: 3.183

5.  Fasting medium chain acyl-coenzyme A dehydrogenase--deficient children can make ketones.

Authors:  J M Fletcher; J J Pitt
Journal:  Metabolism       Date:  2001-02       Impact factor: 8.694

6.  The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states.

Authors:  J P Bonnefont; N B Specola; A Vassault; A Lombes; H Ogier; J B de Klerk; A Munnich; M Coude; M Paturneau-Jouas; J M Saudubray
Journal:  Eur J Pediatr       Date:  1990-12       Impact factor: 3.183

7.  In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.

Authors:  C Jakobs; J Kneer; D Martin; J Boulloche; M Brivet; B T Poll-The; J M Saudubray
Journal:  Eur J Pediatr       Date:  1997-08       Impact factor: 3.183

8.  Increased lipolysis in LCHAD deficiency.

Authors:  M U Halldin; A Forslund; U von Döbeln; C Eklund; J Gustafsson
Journal:  J Inherit Metab Dis       Date:  2006-12-09       Impact factor: 4.982

9.  Reference values of blood components related to fuel metabolism in children after an overnight fast.

Authors:  K J Lamers; W H Doesburg; F J Gabreëls; A C Romsom; W O Renier; R A Wevers; W A Lemmens
Journal:  Clin Chim Acta       Date:  1985-01-15       Impact factor: 3.786

10.  Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  S J Heales; G N Thompson; A F Massoud; S Rahman; D Halliday; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

  10 in total
  5 in total

Review 1.  Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.

Authors:  Allan Meldgaard Lund; Flemming Skovby; Helle Vestergaard; Mette Christensen; Ernst Christensen
Journal:  J Inherit Metab Dis       Date:  2010-01-12       Impact factor: 4.982

2.  Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study.

Authors:  Catharina M L Touw; G Peter A Smit; Maaike de Vries; Johannis B C de Klerk; Annet M Bosch; Gepke Visser; Margot F Mulder; M Estela Rubio-Gozalbo; Bert Elvers; Klary E Niezen-Koning; Ronald J A Wanders; Hans R Waterham; Dirk-Jan Reijngoud; Terry G J Derks
Journal:  Orphanet J Rare Dis       Date:  2012-05-25       Impact factor: 4.123

3.  Transcriptome analysis suggests a compensatory role of the cofactors coenzyme A and NAD+ in medium-chain acyl-CoA dehydrogenase knockout mice.

Authors:  Anne-Claire M F Martines; Albert Gerding; Sarah Stolle; Marcel A Vieira-Lara; Justina C Wolters; Angelika Jurdzinski; Laura Bongiovanni; Alain de Bruin; Pieter van der Vlies; Gerben van der Vries; Vincent W Bloks; Terry G J Derks; Dirk-Jan Reijngoud; Barbara M Bakker
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

4.  In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes.

Authors:  Catharina M L Touw; G Peter A Smit; Klary E Niezen-Koning; Conny Bosgraaf-de Boer; Albert Gerding; Dirk-Jan Reijngoud; Terry G J Derks
Journal:  Orphanet J Rare Dis       Date:  2013-03-20       Impact factor: 4.123

Review 5.  Clinical manifestations and management of fatty acid oxidation disorders.

Authors:  J Lawrence Merritt; Erin MacLeod; Agnieszka Jurecka; Bryan Hainline
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.